From Chagas disease to antibiotic resistant bacteria, Priorclave’s customers are doing important research in modern disease.
Battling Antibiotic Resistance at the DNA Level
The Institute of Structural and Molecular Biology at Birkbeck, University of London—in partnership with the University College London—were the first group to examine the entire structure of Tral, a relaxase protein. Relaxase unwinds DNA, making the transfer of genetic material possible, which is how bacteria develop resistance to antibiotics. Better understanding of this process means scientists can work toward more effective antibiotic therapies.
Chagas Disease on the Rise
Eight time zones away, microbiology researchers at California State University, Fullerton, in the Department of Biological Science, are investigating the adaptive abilities of Trypanosoma cruzi, the parasite that causes Chagas disease. Chagas disease is spreading from South and Central America into the US and Europe at an alarming rate. Although entirely preventable, Chagas disease can lead to serious side effects, including heart failure — and there is currently no FDA-approved cure.
Autoclaves that Pull Their Weight without Bulking Up the Bills
A busy university microbiology lab needs an autoclave that can keep up with their workflow—but standard medical-grade autoclaves (which often idle hot around the clock) are overkill. That’s why Priorclave brought its research-grade autoclaves to North America. Our sterilizers are ready to go when you need them, but they never waste water and energy while sitting idle. The money you save on utilities and maintenance goes right back into research—a benefit Fullerton is already starting to reap.
[Photo credit: Karl-Ludwig Poggemann, CC BY 2.0]